Q2 2025 Hinge Health Inc Earnings Call Transcript

Aug 5, 2025 / 08:30 PM GMT

Release Date Price: $48.22

Transcript 10-Q8-K

Key Points

Positve

Hinge Health Inc (HNGE) reported a 55% year-over-year increase in revenue for Q2 2025, reaching $139 million.
The company achieved a non-GAAP operating margin of 19% and generated $33 million in free cash flow, indicating strong financial health.
Hinge Health Inc (HNGE) has expanded its partnerships, now including over 50 partners, such as the five largest national health plans and the top three PBMs.
The company has launched several innovative products, including AI-powered motion tracking technology and Hinge Select, a high-performance provider network.
Hinge Health Inc (HNGE) has shown strong client retention rates and increased member engagement, with a record high member NPS in the first half of the year.

Negative

The company faces significant competition in the digital musculoskeletal (MSK) space, with competitors expanding into other areas such as mental health.
Hinge Health Inc (HNGE) anticipates minimal revenue impact from its new Hinge Select offering until 2027, indicating a long-term investment without immediate returns.
The company is experiencing increased operating expenses due to investments in R&D and sales and marketing, which may impact short-term profitability.
There are challenges in scaling the business internationally, as the company is currently focusing on US-based multinational corporations rather than building separate sales teams abroad.
Hinge Health Inc (HNGE) faces potential risks from economic cycles, which could impact demand for its cost-saving solutions.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HNGE.N - Hinge Health Inc
Q2 2025 Hinge Health Inc Earnings Call
Aug 05, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for joining us and welcome to the Hinge Health 2nd quarter 2025 earnings call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please raise your hand. If you have dialed in today's call, please press 9 to raise your hand and 6 to unmute. I will now hand the conference over to Bianca Buck, head of investor relations. Bianca, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good afternoon, everyone, and thank you for joining Hinge Health's 2nd quarter 2025 earnings conference call.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.